1263132-31-5 Usage
General Description
1,1-Difluoro-6-azaspiro[2.5]octane hydrochloride is a chemical compound known for its potential applications in organic synthesis and is widely used in the field of pharmaceuticals. 1,1-Difluoro-6-azaspiro[2.5]octane hydrochloride, with the presence of fluoride and chloride ions, belongs to the class of organic compounds called azaspirodecane derivatives. However, not much specific details about this particular chemical have been extensively researched or widely published. Its interaction with other compounds, specific uses, and potential hazards or safety precautions are areas that would require further study.
Check Digit Verification of cas no
The CAS Registry Mumber 1263132-31-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,6,3,1,3 and 2 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1263132-31:
(9*1)+(8*2)+(7*6)+(6*3)+(5*1)+(4*3)+(3*2)+(2*3)+(1*1)=115
115 % 10 = 5
So 1263132-31-5 is a valid CAS Registry Number.
1263132-31-5Relevant articles and documents
Synthesis of Functionalized Difluorocyclopropanes: Unique Building Blocks for Drug Discovery
Bychek, Roman M.,Levterov, Vadym V.,Sadkova, Iryna V.,Tolmachev, Andrey A.,Mykhailiuk, Pavel K.
supporting information, p. 12291 - 12297 (2018/03/28)
Difluorocyclopropane-containing building blocks for drug discovery were synthesized from the functionalized alkenes and TMSCF3/NaI. Novel fluorinated acids, amines, amino acids, alcohols, ketones and sulfonyl chlorides were obtained.
SUBSTITUTED HETEROCYCLIC SULFONAMIDE COMPOUNDS USEFUL AS TRPA1 MODULATORS
-
Paragraph 0946; 0947, (2015/04/28)
The invention is concerned with the compounds of formula I or II: and salts thereof. In addition, the present invention relates to methods of manufacturing and methods of using the compounds of formula I or II as well as pharmaceutical compositions containing such compounds. The compounds may be useful in treating diseases and conditions mediated by TRPA1, such as pain.
